A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Sofetabart Mipitecan
Related studies linked through entity extraction aliases.